SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-23-000326
Filing Date
2023-02-22
Accepted
2023-02-22 07:30:33
Documents
13
Period of Report
2023-02-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 8-K a53335402.htm   iXBRL 8-K 27163
2 EXHIBIT 99.1 a53335402_ex991.htm EX-99.1 573784
  Complete submission text file 0001157523-23-000326.txt   772217

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crl-20230222.xsd EX-101.SCH 3914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crl-20230222_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crl-20230222_pre.xml EX-101.PRE 16037
7 EXTRACTED XBRL INSTANCE DOCUMENT a53335402_htm.xml XML 4077
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

IRS No.: 061397316 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 23650541
SIC: 8731 Services-Commercial Physical & Biological Research